Hepatitis B virus infection is a prognostic biomarker for better survival in operable esophageal cancer: Analysis of 2004 patients from an endemic area in China
Cancer Epidemiology, Biomarkers & Prevention | Mar 20, 2019
Lack of association between human papillomavirus types 6 and 11 genetic variants and cervical abnormalities: The Ludwig-McGill cohort study
Cancer Epidemiology, Biomarkers & Prevention | Mar 20, 2019
Bacterial translocation and risk of liver cancer in a Finnish cohort
Cancer Epidemiology, Biomarkers & Prevention | Mar 20, 2019
Microrna dysregulation and non-muscle-invasive bladder cancer prognosis
Cancer Epidemiology, Biomarkers & Prevention | Mar 20, 2019
TBCRC 022: A phase II trial of neratinib and capecitabine for patients with human epidermal growth factor receptor 2–positive breast cancer and brain metastases
Journal of Clinical Oncology | Mar 19, 2019